Diffuse systemic sclerosis and autoimmune hepatitis: A unique association

Clinical Rheumatology

Volumn 29, Issue 7, 2010, Pages 799-801

  Rodrigues, Carlos Ewerton Maia ^a   Borges, Cláudia Lobato ^a   De Carvalho, Jozélio Freire ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Autoimmune hepatitis; Hepatitis; Scleroderma; Systemic sclerosis

Indexed keywords

AZATHIOPRINE; COLCHICINE; MITOCHONDRION ANTIBODY; PENICILLAMINE; PREDNISONE; IMMUNOSUPPRESSIVE AGENT;

ADULT; ARTICLE; AUTOIMMUNE HEPATITIS; CASE REPORT; DRUG DOSE REDUCTION; DRUG WITHDRAWAL; FEMALE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LIVER BIOPSY; LIVER NECROSIS; PRIORITY JOURNAL; RARE DISEASE; SYSTEMIC SCLEROSIS; UNITED STATES; BLOOD; COMPLICATION; MIDDLE AGED; SCLERODERMA, DIFFUSE; TREATMENT OUTCOME;

FEMALE; HEPATITIS, AUTOIMMUNE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MIDDLE AGED; SCLERODERMA, DIFFUSE; TREATMENT OUTCOME;

EID: 77956275020     PISSN: 07703198     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10067-010-1390-x     Document Type: Article

References (14)

1. Abu-Shakra M, Guillemin F, Lee P (1994) Gastrointestinal manifestations of systemic sclerosis. Semin Arthritis Rheum 24:29-39
2. Marie I, Levesque H, Tranvouez JL, François A, Riachi G, Cailleux N, Courtois H (2001) Autoimmune hepatitis and systemic sclerosis: a new overlap syndrome? Rheumatology (Oxford) 40:102-106
3. McFarlane IG (1998) The relationship between autoimmune markers and different clinical syndromes in autoimmune hepatitis. Gut 42:599-602
4. Khalifa M, Ben Jazia E, Hachfi W, Sriha B, Bahri F, Letaief A (2006) Autoimmune hepatitis and morphea: a rare association. Gastroenterol Clin Biol 30:917-918
5. West M, Jasin HE, Medhekar S (2006) The development of connective tissue diseases in patients with autoimmune hepatitis: a case series. Semin Arthritis Rheum 35:344-348
6. Narbutt J, Lesiak A, Kwiecień A, Sysa-Jedrzejowska A, Kuydowicz J (2005) Scleroderma-like lesions in the course of autoimmune hepatitis. Przegl Lek 62:314-316
7. Lis-Swiety A, Brzezinska-Wcislo L, Pierzchala E, Wcislo-Dziadecka D (2006) Systemic sclerosis-polymyositis overlap syndrome accompanied by autoimmune hepatitis and sarcoidosis of mediastinal lymph nodes. J Eur Acad Dermatol Venereol 20:107-108
8. Ngo Mandag N, Van Gossum M, Rickaert F, Golstein M (2007) Autoimmune hepatitis and CREST syndrome. Rev Med Brux 28:528-531
9. Ishikawa M, Okada J, Shibuya A, Kondo H (1995) CRST syndrome (calcinosis cutis, Raynaud's phenomenon, sclerodactyly, and telangiectasia) associated with autoimmune hepatitis. Intern Med 34:6-9
10. Yabe H, Noma K, Tada N, Mochizuki S, Nagano M (1992) A case of CREST syndrome with rapidly progressive liver damage. Intern Med 31:69-73
11. Montano-Loza AJ, Carpenter HA, Czaja AJ (2008) Frequency, behavior, and prognostic implications of antimitochondrial antibodies in type 1 autoimmune hepatitis. J Clin Gastroenterol 42:1047-1053
12. D'Angelo WA, Fries JF, Masi AT, Schulman LE (1969) Pathologic observations in systemic sclerosis (scleroderma): a study of fifty-eight autopsy cases and fifty-eight matched controls. Am J Med 46:428-440
13. White B (2001) Systemic sclerosis, epidemiology, pathology and pathogenesis. In Primer on the rheumatic diseases. 2nd ed, Canada, Arthritis Foundation, 353-356
14. Steen VD, Medsger TA Jr (1998) Case-control study of corticosteroids and other drugs that either precipitate or protect from the development of scleroderma renal crisis. Arthritis Rheum 41:1613-1619